Cardiomegaly

2

Review clinical trials related to Cardiomegaly. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial

This study aims to evaluate whether the use of AI as a physician support tool is associated with an increase in the detection rate of chest radiographic findings in adults with respiratory complaints, compared to diagnosis performed exclusively by doctors, without AI support. This is a cluster-randomized clinical trial, following the stepped wedge design, and adhering to the guidelines of the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT). In this study, the Diagnostic Support Solution for Chest X-rays - LungAnalysis (LuAna), developed by the Hospital Israelita Albert Einstein (HIAE) within the PROADI-SUS Banco de Imagens, was used. The clinical trial will be conducted in multiple centers with a diverse population from the public health system, to ensure that the algorithms are validated across a broad demographic profile. The expected benefits are significant, providing greater security for patients, increasing doctors' confidence in interpreting chest X-rays, promoting efficiency and cost savings for healthcare services, and offering promising prospects for other AI applications in imaging diagnostics.

Participants needed: 1,470
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Hospital Israelita Albert EinsteinUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Non-reported chest X-rays (XRts) of individuals aged over 18 years. [+4]

Those whose chest X-ray was performed due to a history of trauma, pre-operative... [+3]

Status: Recruiting

MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies

The goal of this study is to evaluate the effectiveness of trametinib treatment in patients with Hyperthropic cardiomyopathy and a genetic mutation in the RAS/MAPK pathway.

Participants needed: 40
Trial details
Phase: Phase 2Age: 1-18Biological sex: AllType: InterventionalSponsor: Medical University of WarsawUpdated: Aug 15, 2024Locations: 1
Eligibility criteria

patient with diagnosed RASopathy [+2]

contraindications to treatment with propranolol (drug hypersensitivity, atrioven... [+1]